Evaluate and compare efficacy of demineralised freeze bone allograft around immediate flapless implant.

Not Applicable

• Registration Number: CTRI/2021/01/030620
• Lead Sponsor: Dr Mukesh Purohit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Systemically healthy patients.

2.Patient with healthy and stable soft tissue architecture

3.Sites at which minimum torque of 35 Ncm is obtained at the time of implant insertion.

4.Co-operative, motivated and hygiene conscious patients

5.Tooth/teeth with Grade I or II mobility required to be extracted.

6.Root stumps

7.Tooth with endodontic failure or non restorable caries or vertical fracture.

8.Chronic periodontal disease with hopeless prognosis.

Exclusion Criteria

1.General contraindications to implant surgery.

2.Patients with a history of irradiation in the head and neck area, within the last 6 months.

3.Treated or under treatment with intravenous amino-bisphosphonates.

4.Smokers or patients with poor oral hygiene.

5.Patients with para-functional habits.

6.Pregnant or lactating females.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
to evaluate and compare the hard and soft tissue changes in immediate implant placement using flapless approach with and without DFDBA clinically and radio graphically using CBCTTimepoint: 1.To evaluate and compare the hard tissue changes in immediate implant placement with flapless approach with and without DFDBA at baseline and 6 months post surgery using CBCT. <br/ ><br>2.To evaluate and compare the soft tissue changes in immediate implant placement using flapless approach with and without DFDBA at baseline and 6 months post surgery using CBCT. <br/ ><br>3 To assess Peri-implant soft tissues with Testori Implant Esthetic Score <br/ ><br> <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
1.To evaluate and compare the hard tissue changes in immediate implant placement with flapless approach with and without DFDBA at baseline and 6 months post surgery using CBCT. <br/ ><br>2.To evaluate and compare the so tissue changes in immediate implant placement using flapless approach with and without DFDBA at baseline and 6 months post surgery using CBCT. <br/ ><br>3.To assess Peri-implant soft tissues with Testori Implant Esthetic Score <br/ ><br>Timepoint: 18 Months